Sumitomo Pharma , Ltd. Profit Margin

Sumitomo Pharma , Ltd. posts a profit margin of 23.77% as of June 2026. That compares with 4.54% in the prior-year period — up 423.3% year over year. That is above the sector sector average of 13.2%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Sumitomo Pharma , Ltd.'s profit margin was 4.54%. The latest reading is 23.77% — a 423.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.2% is typical. Sumitomo Pharma , Ltd.'s 23.77% is higher that level. That is roughly 80.1% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Sumitomo Pharma , Ltd.'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 23.77% as of June 2026; use YoY and peer views to separate noise from signal.

Context for DNPUF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.2%), and (3) consistency with growth and profitability. This page covers the first two; Sumitomo Pharma , Ltd.'s other metric pages and overview cover the third.